Biliary dyskinesia and symptomatic gallstone disease in children: two sides of the same coin?

Arvind I Srinath1, Ada O Youk, Klaus Bielefeldt

  • 1Division of Pediatric Gastroenterology, Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center (UPMC), 4401 Penn Avenue, Pittsburgh, PA, 15224, USA, arvind.srinath@chp.edu.

Insights

Biliary dyskinesia (BD) in children presents with more widespread symptoms and higher post-surgery resource use compared to symptomatic cholecystolithiasis. BD often mimics functional gastrointestinal disorders and may benefit from similar treatment approaches.

Area of Science:

  • Pediatric Gastroenterology
  • Hepatobiliary Disorders
  • Surgical Outcomes

Background:

  • Biliary dyskinesia (BD) is an increasingly recognized diagnosis in children, despite a lack of consensus diagnostic criteria.
  • This study compares pediatric patients diagnosed with BD versus symptomatic cholecystolithiasis (LITH).

Purpose of the Study:

  • To compare patient characteristics, treatment outcomes, and resource utilization in children with BD versus LITH.
  • To analyze factors predicting persistent pain and resource utilization after cholecystectomy in these pediatric groups.

Main Methods:

  • Retrospective review of electronic medical records for children diagnosed with BD or LITH between 2002 and 2012.
  • Comparison of demographic data, symptom profiles, surgical interventions, and post-operative clinical resource use between the two groups.

Main Results:

  • Children with BD had lower BMI, longer symptom duration, and more dyspeptic and other symptoms compared to LITH patients.
  • 13.8% of BD patients underwent cholecystectomy with a normal gallbladder ejection fraction; sincalide-induced pain was noted in 32 of these.
  • Post-surgery, BD patients had more gastroenterology clinic visits and GI hospitalizations, with disease type predicting persistent pain and higher resource use.

Conclusions:

  • A significant proportion of pediatric BD patients do not meet adult diagnostic criteria.
  • Children with BD exhibit broader symptoms and higher post-operative clinical resource utilization than those with LITH.
  • BD shares characteristics with functional gastrointestinal disorders (FGIDs) and may warrant FGID-focused treatment strategies despite its benign prognosis.
Abstract

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
29
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
1.2K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
900
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
818